Go to JCI Insight
  • About
  • Editors
  • Consulting Editors
  • For authors
  • Publication ethics
  • Publication alerts by email
  • Advertising
  • Job board
  • Contact
  • Clinical Research and Public Health
  • Current issue
  • Past issues
  • By specialty
    • COVID-19
    • Cardiology
    • Gastroenterology
    • Immunology
    • Metabolism
    • Nephrology
    • Neuroscience
    • Oncology
    • Pulmonology
    • Vascular biology
    • All ...
  • Videos
    • Conversations with Giants in Medicine
    • Video Abstracts
  • Reviews
    • View all reviews ...
    • Complement Biology and Therapeutics (May 2025)
    • Evolving insights into MASLD and MASH pathogenesis and treatment (Apr 2025)
    • Microbiome in Health and Disease (Feb 2025)
    • Substance Use Disorders (Oct 2024)
    • Clonal Hematopoiesis (Oct 2024)
    • Sex Differences in Medicine (Sep 2024)
    • Vascular Malformations (Apr 2024)
    • View all review series ...
  • Viewpoint
  • Collections
    • In-Press Preview
    • Clinical Research and Public Health
    • Research Letters
    • Letters to the Editor
    • Editorials
    • Commentaries
    • Editor's notes
    • Reviews
    • Viewpoints
    • 100th anniversary
    • Top read articles

  • Current issue
  • Past issues
  • Specialties
  • Reviews
  • Review series
  • Conversations with Giants in Medicine
  • Video Abstracts
  • In-Press Preview
  • Clinical Research and Public Health
  • Research Letters
  • Letters to the Editor
  • Editorials
  • Commentaries
  • Editor's notes
  • Reviews
  • Viewpoints
  • 100th anniversary
  • Top read articles
  • About
  • Editors
  • Consulting Editors
  • For authors
  • Publication ethics
  • Publication alerts by email
  • Advertising
  • Job board
  • Contact
Top
  • View PDF
  • Download citation information
  • Send a comment
  • Terms of use
  • Standard abbreviations
  • Need help? Email the journal
  • Top
  • Abstract
  • Version history
  • Article usage
  • Citations to this article

Advertisement

Research Article Free access | 10.1172/JCI119721

A p47-phox pseudogene carries the most common mutation causing p47-phox- deficient chronic granulomatous disease.

A Görlach, P L Lee, J Roesler, P J Hopkins, B Christensen, E D Green, S J Chanock, and J T Curnutte

The Scripps Research Institute, Department of Molecular & Experimental Medicine, La Jolla, California 92037, USA.

Find articles by Görlach, A. in: PubMed | Google Scholar

The Scripps Research Institute, Department of Molecular & Experimental Medicine, La Jolla, California 92037, USA.

Find articles by Lee, P. in: PubMed | Google Scholar

The Scripps Research Institute, Department of Molecular & Experimental Medicine, La Jolla, California 92037, USA.

Find articles by Roesler, J. in: PubMed | Google Scholar

The Scripps Research Institute, Department of Molecular & Experimental Medicine, La Jolla, California 92037, USA.

Find articles by Hopkins, P. in: PubMed | Google Scholar

The Scripps Research Institute, Department of Molecular & Experimental Medicine, La Jolla, California 92037, USA.

Find articles by Christensen, B. in: PubMed | Google Scholar

The Scripps Research Institute, Department of Molecular & Experimental Medicine, La Jolla, California 92037, USA.

Find articles by Green, E. in: PubMed | Google Scholar

The Scripps Research Institute, Department of Molecular & Experimental Medicine, La Jolla, California 92037, USA.

Find articles by Chanock, S. in: PubMed | Google Scholar

The Scripps Research Institute, Department of Molecular & Experimental Medicine, La Jolla, California 92037, USA.

Find articles by Curnutte, J. in: PubMed | Google Scholar

Published October 15, 1997 - More info

Published in Volume 100, Issue 8 on October 15, 1997
J Clin Invest. 1997;100(8):1907–1918. https://doi.org/10.1172/JCI119721.
© 1997 The American Society for Clinical Investigation
Published October 15, 1997 - Version history
View PDF
Abstract

The predominant genetic defect causing p47-phox-deficient chronic granulomatous disease (A47 degrees CGD) is a GT deletion (DeltaGT) at the beginning of exon 2. No explanation exists to account for the high incidence of this single mutation causing a rare disease in an unrelated, racially diverse population. In each of 34 consecutive unrelated normal individuals, both the normal and mutant DeltaGT sequences were present in genomic DNA, suggesting that a p47-phox related sequence carrying DeltaGT exists in the normal population. Screening of genomic bacteriophage and YAC libraries identified 13 p47-phox bacteriophage and 19 YAC clones. The GT deletion was found in 11 bacteriophage and 15 YAC clones. Only 5 exonic and 33 intronic differences distinguished all DeltaGT clones from all wild-type clones. The most striking differences were a 30-bp deletion in intron 1 and a 20-bp duplication in intron 2. These results provide good evidence for the existence of at least one highly homologous p47-phox pseudogene containing the DeltaGT mutation. The p47-phox gene and pseudogene(s) colocalize to chromosome 7q11.23. This close linkage, together with the presence within each gene of multiple recombination hot spots, suggests that the predominance of the DeltaGT mutation in A47 degrees CGD is caused by recombination events between the wild-type gene and the pseudogene(s).

Version history
  • Version 1 (October 15, 1997): No description

Article tools

  • View PDF
  • Download citation information
  • Send a comment
  • Terms of use
  • Standard abbreviations
  • Need help? Email the journal

Metrics

  • Article usage
  • Citations to this article

Go to

  • Top
  • Abstract
  • Version history
Advertisement
Advertisement

Copyright © 2025 American Society for Clinical Investigation
ISSN: 0021-9738 (print), 1558-8238 (online)

Sign up for email alerts